The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKibo Energy Regulatory News (KIBO)

Share Price Information for Kibo Energy (KIBO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0375
Bid: 0.035
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.005 (14.286%)
Open: 0.0425
High: 0.0425
Low: 0.0375
Prev. Close: 0.0375
KIBO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partial Settlement of Outstanding Shareholder Loan

5 Oct 2023 07:00

RNS Number : 7414O
Kibo Energy PLC
05 October 2023
 

Kibo Energy PLC (Incorporated in Ireland)

(Registration Number: 451931)

(External registration number: 2011/007371/10)

LEI Code: 635400WTCRIZB6TVGZ23

Share code on the JSE Limited: KBO

Share code on the AIM: KIBO

ISIN: IE00B97C0C31

('Kibo' or 'the Company')

 

Dated: 5 October 2023

 

Kibo Energy PLC ('Kibo' or the 'Company')

 

Partial Settlement of Outstanding Shareholder Loan Owing by Mast Energy Developments PLC ('MED')

 

Kibo Energy PLC (AIM: KIBO; AltX: KBO) ('Kibo' or the 'Company'), the renewable energy focused development company, has today received 31,646,424 new MED Shares of £0.001 each ("the Settlement Shares") at a deemed issue price of £0.01482 per share ("Settlement Share Price") from its subsidiary, Mast Energy Developments PLC ("MED"), having mutually agreed the partial settlement of £469,000  (the "Partial Settlement") of the total outstanding amount owing to Kibo's wholly owned subsidiary, Kibo Mining (Cyprus) Limited ('Kibo Cyprus').

 

Following the Partial Settlement, the remaining outstanding shareholder loan amount owed by MED is £762,535. The Settlement Share Price is the 20-day VWAP for the period up to the closing price of the MED shares on the London Stock Exchange on 2 October 2023.

 

Following the Partial Settlement, Kibo will hold 147,811,746 Ordinary Shares representing a 56.02% interest in MED.

 

Kibo is working with its advisors and funders to assist MED in ensuring that MED is sufficiently funded for their immediate capital requirements which includes the possibility to potentially advance further funds in the near-term to provide interim funding pending completion of the previously announced MED joint venture. The Kibo board remain confident, alongside the MED board, that the joint venture (as last updated on RNS 22 September 2023) can be concluded as proposed despite the unforeseen delays arising from the exceptional events confirmed in earlier announcements.

 

Louis Coetzee, CEO of Kibo Energy, says: "We are pleased to announce the Partial Settlement of the MED Loan, which has been agreed on favourable terms to both Kibo and MED whilst minimizing shareholder dilution in MED. The favourable settlement terms with the extended pricing period not only highlights Kibo's ongoing support of MED but also illustrates its firm belief in MED's future success and anticipated conclusion of its previously announced joint venture. We are committed to continuing to support MED and Kibo's other investments."

 

**ENDS**

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

For further information please visit www.kibo.energy or contact:

 

Louis Coetzee

info@kibo.energy

Kibo Energy PLC

Chief Executive Officer

Andreas Lianos

+357 99 53 1107

River Group

JSE Corporate and Designated Adviser

Claire Noyce

+44 (0) 20 3764 2341

Hybridan LLP

Joint Broker

Damon Heath

+44 207 186 9952

Shard Capital Partners LLP

Joint Broker

James Biddle Roland Cornish

+44 207 628 3396

Beaumont Cornish Limited

Nominated Adviser

Zainab Slemang van Rijmenant

zainab@lifacommunications.co.za

Lifa Communications

Investor and Media Relations Consultant

 

Notes

Kibo Energy PLC is a renewable energy focused development company with its primary focus to advance its business as a significant diversified energy developer of sustainable power solutions that integrate existing and emerging Renewable Generation technology, Waste-to-Energy technology and Energy Storage technology in southern and eastern Africa, and the United Kingdom.

 

Additionally, the Company has a majority interest in MAST Energy Developments Limited ('MED'), a private UK registered company targeting the development and operation of flexible power plants to service the UK Reserve Power generation market.

 

Johannesburg

5 October 2023

Corporate and Designated Adviser River Group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZLFBXBLEFBF
Date   Source Headline
26th Apr 20247:00 amRNSKibo Subsidiary Announces Business Update
23rd Apr 20242:30 pmRNSKibo Subsidiary Announces Major Shareholdings
11th Apr 20247:00 amRNSKibo Subsidiary MAST Announces Business Update
5th Mar 20247:00 amRNSIssue of Shares to Service Provider
4th Mar 202410:45 amRNSKibo Subsidiary Announces TR-1 Notification
28th Feb 20247:00 amRNSMAST New Funding Partner & Proventure Cancellation
21st Feb 20242:46 pmRNSHolding(s) in Company
20th Feb 20241:00 pmRNSKibo Subsidiary Announces TR-1 Notification
9th Feb 202412:45 pmRNSResults of Extraordinary General Meeting
5th Feb 20241:55 pmRNSKibo Subsidiary MAST Announces TR-1 Notification
31st Jan 202410:48 amRNSDirector/PDMR Shareholding
24th Jan 20243:45 pmRNSKibo Subsidiary MAST Announces TR-1 Notification
19th Jan 20241:52 pmRNSPDMR Share Sale
18th Jan 20247:00 amRNSNotice of Extraordinary General Meeting (“EGM”)
16th Jan 202410:50 amRNSCorrection on MED Shareholding
16th Jan 20247:00 amRNSKibo Strategy Update
11th Jan 20247:00 amRNSConversion, Equity Issue, TVR & Board Changes
8th Jan 20247:00 amRNSKibo Subsidiary Announces an Update on JVA
2nd Jan 20247:00 amRNSKibo Subsidiary - Further Update of Payment to JVA
22nd Dec 20237:00 amRNSKibo Subsidiary Announces JVA Completion Update
19th Dec 20232:00 pmRNSPDMR Share Sale
15th Dec 20237:00 amRNSSubsidiary Director Loan & PMDR Share Sale
11th Dec 20238:21 amRNSKibo Subsidiary Update JVA Completion Announcement
11th Dec 20237:00 amRNSMAST: Further Update to the Completion of JVA
7th Dec 20232:15 pmRNSResult of AGM
1st Dec 20237:00 amRNSKibo Subsidiary Announces Update of JVA
15th Nov 20237:00 amRNSNotice of AGM
13th Nov 20237:00 amRNSKibo UK Subsidiary JVA Interim Payment Update
26th Oct 20237:00 amRNSChange of Holding in Mast Energy Developments PLC
23rd Oct 20237:00 amRNSKibo Subsidiary - Update on the Completion of JVA
5th Oct 20237:00 amRNSPartial Settlement of Outstanding Shareholder Loan
4th Oct 20237:00 amRNSSale of Coal Interest in Botswana Power Project
29th Sep 20237:00 amRNSUnaudited Interim Results
22nd Sep 20237:00 amRNSKibo Subsidiary Announces Update on JVA Completion
1st Sep 20237:00 amRNSKibo Subsidiary Announces Further Update on JVA
25th Aug 20237:00 amRNSKibo Subsidiary MED Unaudited Interim Results
16th Aug 202310:10 amRNSClarification on Inaccurate Moneyweb Article
7th Aug 202310:25 amRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSKibo Subsidiary Announces Update on JV Completion
31st Jul 20237:00 amRNSUpdate on MED Definitive and Binding JVA
24th Jul 20234:40 pmRNSTR-1: Notification of major holdings
12th Jul 20231:15 pmRNSKibo Subsidiary Announces Definitive & Binding JVA
3rd Jul 20237:00 amRNSOperational Update: Q2 2023
29th Jun 20237:00 amRNSAnnual Financial Report
16th Jun 20233:51 pmRNSHolding(s) in Company
2nd Jun 20232:30 pmRNSResults of EGM
26th May 202312:15 pmRNSWarrant Exercise
23rd May 20232:30 pmRNSKibo Subsidiary MED Issue of Shares
22nd May 20233:00 pmRNSKibo Subsidiary Issue of Shares
18th May 20237:00 amRNSMED Update, JV and Reprofiling of Loan Facilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.